Another 3 species passed the consistency evaluation; Fosun, humanwell and Neptune

Today morning, Haiwang biology released an enterprise announcement that its holding subsidiary Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd (hereinafter referred to as "Haiwang Fuyao") recently received the "supplementary application approval for drugs" of "sodium bicarbonate tablet" approved and issued by the State Drug Administration, which passed the consistency evaluation of quality and efficacy of generic drugs Coincidentally, yesterday, Fosun Pharmaceutical also announced that its holding subsidiary Shenyang Hongqi Pharmaceutical Co., Ltd (hereinafter referred to as "Shenyang Hongqi") has received the approval document for supplementary application of isoniazid tablets (hereinafter referred to as "the drug") issued by the State Drug Administration (approval document No.: 2019b02684), which has passed the consistency evaluation of generic drugs At the same time, it is found that paracetamol tablets of Yichang humanwell Pharmaceutical Co., Ltd are included in the list of Chinese listed drugs through a small compilation According to relevant policies, they are deemed to have passed the consistency evaluation The sodium bicarbonate tablet "sodium bicarbonate tablet" of haiwangfu medicine is used to relieve the stomach pain, heartburn (heartburn) and acid regurgitation caused by excessive gastric acid, and has entered the national class a medical insurance catalog in 2017 and the national basic medicine catalog in 2018 In 2018, the sales volume of haiwangfu medicine is about 12 million yuan The specification of sodium bicarbonate tablet reviewed by haiwangfu is 0.5g According to the data of Yaozhi, another acceptance number has also been approved, and the processing status has been sent The review will be ready in the near future It is worth mentioning that sodium bicarbonate tablets have 475 domestic market approvals, involving 158 manufacturers, of which only 8 enterprises have applied for conformity assessment Fuzhou Haiwang Pharmaceutical Co., Ltd is the first one to pass the conformity assessment this time According to relevant national policies, the drug varieties that pass the conformity assessment get certain support in drug bidding, medical insurance payment and other aspects, so it is trying to win the government At the same time, it is beneficial to improve the market competitiveness of products In addition, Hunan Hansen Pharmaceutical Co., Ltd and Yuanda Pharmaceutical Co., Ltd have recently approved the sodium bicarbonate tablets, which are in the "delivered" state It is believed that the good news of the three full members of the variety will come soon Details of consistency evaluation of sodium bicarbonate tablet isoniazid tablet is suitable for the treatment of various types of tuberculosis, mainly used in combination with other anti tuberculosis drugs According to the latest data of iqviachpa, in 2018, the sales volume of isoniazid tablets in China was about 94.36 million yuan; the sales volume of Shenyang Hongqi in China (excluding Hong Kong, Macao and Taiwan, the same below) was about 29.09 million yuan (Unaudited) In addition, according to the announcement, as of March 2019, Fosun Pharmaceutical has invested about 4.9 million yuan (Unaudited) in the research and development of the conformity evaluation of the product According to the pharmaceutical intelligence data, at present, there are eight enterprises applying for the consistency evaluation of this variety, and two enterprises, Shenyang Hongqi and Huazhong pharmaceutical, have completed the approval Shenyang Hongqi is the first one to pass the evaluation Details of application for acceptance of isoniazid tablets consistency evaluation Acetaminophen tablet is a kind of antipyretic and analgesic drug, which belongs to the national basic drug catalog It belongs to class B over-the-counter drug It is a classic antipyretic drug, widely used for fever caused by common cold or influenza, and also used to relieve mild to moderate pain, such as headache, joint pain, migraine, toothache, muscle pain, neuralgia and dysmenorrhea According to the drug registration and acceptance database, there are 16 enterprises applying for the consistency evaluation of acetaminophen tablets at present, of which three have been approved, but Sinopharm group has not been approved for supplement, and Chengdu pharmaceutical industry of Di'ao group has been the first evaluated enterprise This time, Yichang humanwell pharmaceutical industry has passed, and it is the second evaluated enterprise Data source of acceptance details of paracetamol tablet consistency evaluation declaration: drug intelligence data, enterprise announcement and other statements: this opinion only represents the author, not the position of drug intelligence network, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.